Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality.

ABSTRACT:

Importance

While symptomatic vitreomacular interface abnormalities (VIAs) are common, assessment of vision preference values and treatment preferences of these may guide treatment recommendations by physicians and influence third-party payers.

Objective

To determine preference values that individuals with VIA assign to their visual state and preferences of potential treatments.

Design, setting, and participants

In this cross-sectional one-time questionnaire study conducted between December 2015 and January 2017, 213 patients from tertiary care referral centers in Thailand, the United Kingdom, and the United States were studied. Patients with symptomatic VIA diagnosed within 1 year of data collection, visual acuity less than 20/20 OU, and symptoms ascribed to VIAs were

SUBMITTER: Linz MO 

PROVIDER: S-EPMC6145775 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature